Medable, a clinical development technology platform, has launched an AI agent to assist principal investigators with oversight of electronic clinical outcome assessment data at research sites. The PI Summary Agent continuously monitors participant eCOA data, generating summaries and highlighting critical data points whilst maintaining human oversight. The agent addresses regulatory requirements for oversight of remotely captured data, which traditionally required manual verification across multiple systems. It centralises participant data inputs to streamline remote monitoring without disrupting trial operations. Released following Medable's TMF and CRA agents, the new capability is available now as part of Medable's eCOA platform. The company's platform has been deployed in nearly 400 trials across 70 countries, serving over one million patients globally.

That same year, CVS teamed up with Medable on an initiative to grow clinical trial engagement at the former's CVS MinuteClinics.